Neumora Therapeutics (NMRA) Non-cash Items (2022 - 2026)

Neumora Therapeutics' Non-cash Items history runs 5 years deep, the most recent figure standing at $10.5 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 61.19% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.5 million (up 61.19% YoY), while the FY2025 annual figure was $7.9 million, up 50.89% from the prior year.
• Non-cash Items was $10.5 million for Q1 2026 at Neumora Therapeutics, up from $2.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $147.0 million in Q4 2023 to a low of $2.7 million in Q4 2025.
• Historically, Non-cash Items has averaged $47.6 million across 5 years, with a median of $33.9 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Non-cash Items surged 510.2% in 2023, then tumbled 93.97% in 2025.
• A 5-year view of Non-cash Items shows it stood at $24.1 million in 2022, then soared by 510.2% to $147.0 million in 2023, then sank by 69.41% to $45.0 million in 2024, then sank by 93.97% to $2.7 million in 2025, then jumped by 286.01% to $10.5 million in 2026.
• The last three Non-cash Items figures came in at $10.5 million (Q1 2026), $2.7 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.